Method and composition to reduce myocardial reperfusion injury
CA 2103458 C · Owner: Jackson, Edwin K. · Inventors: Jackson, Edwin K.; Forman, Mervyn B.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to a method to treat a heart attack victim to reduce heart muscle damage. In particular, the invention relates to a method to reduce myocardial reperfusion injury by selectively administering a nonhypotensive amount of a compound that selectively activates adenosine-1 receptor a compound that selectively , activates adenosine-2 receptor or an adenosine, all in the presence of an effective amount of lidocaine.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 26, 1992 and granted November 14, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 26, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 26, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.